Bacterial microbiome is an intelligent living organism, its existence for the organism in the end is symbiotic beneficial bacteria or harmful bacteria with toxicity, such a delineation of the boundaries should take into account not only the characteristics of the bacteria themselves, the composition of the microbial ratio, but also should take into account the hosts own functional conditions, assuming that the purpose of our medicine is to guide the adjustment of the bacterial microbiome, the use of the bacterial microbiome, so as to let it give play to its own complex, multi-faceted and subtle functions, through the treatment of disease in this way may be more comprehensive
Be the first to write a review
Using real-world data to strengthen GLP-1 treatment and commercial outcomes Digital companions not only support patients but also offer pharmaceutical manufacturers valuable real-world data (RWD) which gets them closer to the patient
On the other hand, there is no strong evidence suggesting that acquired hypothyroidism could be a risk factor for schizophrenia or bipolar disorder
Findings suggest that GLP-1 RAs are associated with reduced risk of MACE, and MI among people with OW/OB, but they were driven by studies with established CVD at baseline
Some patients reach their natural set point for their current medication and physiology
